© 2025 - 2026
The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes
EHA 2026 data challenges current intensive therapy strategies for AML with myelodysplasia-related changes and therapy-related AML.